
McDonald's Tests Healthier Menu Items to Court GLP-1 Drug Users
McDonald's is testing menu items like bowls and grilled chicken to appeal to customers using GLP-1 weight-loss drugs. The move aims to capture a growing demographic that seeks lower-calorie, higher-protein options. This strategy reflects a broader industry shift toward health-conscious fast food as GLP-1 usage expands.
